Nanox Release
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.nanoxrelease.comRevenue
$6.6 MillionIndustry
About Nanox Release
Nanox is a nano-biotechnology company, constantly engaged in the research and development of advanced discovery, testing and commercialization of nano-pharmaceutical drugs. The company has developed and specialized in conventional liposomes, pegylated liposomes, and microspheres depot with PLGA (polylactide - polyglycolide copolymers) formulations. These technologies are applicable to drugs, small molecules, peptides and proteins. Nanox's current activities have focused on the clinical development of nano-particulate targeting of drug to specific tissues with promise of progressive treatment and innovative therapeutics options with high efficacy and less side effects for patients with high unmet medical needs. As a fully integrated nanotechnology company, Nanox delivers innovative nanotech solutions, across discovery and development. The company's core business focuses in the development and innovation of alternative nanotech drug delivery processes and products destined to complex treRead more
SIC Code 28,283NAICS Code 32,325Show moreNanox Release Org Chart
Nanox Release Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanox Release
Sign Up For FreeTo access detailed company insights
Nanox is a nano-biotechnology company, constantly engaged in the research and development of advanced discovery, testing and commercialization of nano-pharmaceutical drugs. The company has developed and specialized in conventional liposomes, pegylated liposomes, and microspheres depot with PLGA (polylactide - polyglycolide copolymers) formulations.... Read More